PAR-25-044-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) for the Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) grant. The NCI is inviting applications for investigator-initiated studies addressing how bariatric surgery impacts cancer risk, rather than short-term outcomes like weight loss and diabetes. The goal is to support proof of concept studies for feasibility and exploratory development. Eligible applicant types include special district governments, for-profit organizations, nonprofits, tribal organizations, and state/local governments. The funding opportunity is assigned to the Cancer Cause and Prevention Research, Cancer Control, and Cancer Biology Research federal grant programs. The agency providing the funding is the U.S. Department of Health and Human Services National Institutes of Health.